Antonio Hardan
Stanford University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
15
1 more share only the name and are not shown
Trial papers
26
PubMed author-name match
Trials
Studies that name Antonio Hardan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:18 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07522190 · Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With AutismStanford University · not yet recruiting · Autism Spectrum Disorder (ASD), Autism · principal investigator
- N/ANCT06362733 · Modified Pivotal Response Treatment for Insistence on Sameness in Autistic YouthStanford University · recruiting · Autism Spectrum Disorder, Restricted Behavior, Autism · principal investigator
- Ph1/Ph2NCT06080165 · Sirolimus for Improving Social Abilities in People With PTEN Germline MutationsStanford University · withdrawn · PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome · principal investigator
- N/ANCT04026386 · A Center Based Early Intervention Program For Preschoolers With Developmental DisordersStanford University · recruiting · Development Disorder, Child, Developmental Disability, Development Delay · principal investigator
- Ph2NCT03866668 · A Study of Esomeprazole in Children With AutismStanford University · recruiting · Autism, Autism Spectrum Disorder · principal investigator
- N/ANCT03583684 · Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With AutismStanford University · recruiting · Autism Spectrum Disorder, Autism · principal investigator
- N/ANCT02461446 · Natural History Study of Individuals With Autism and Germline Heterozygous PTEN MutationsBoston Children's Hospital · active not recruiting · PTEN, ASD, Autism · study chair
- N/ANCT02400177 · Parents Workgroup About Emotion RegulationStanford University · completed · Autism Spectrum Disorders · principal investigator
- N/ANCT02037022 · Pivotal Response Treatment Package for Young Children With AutismStanford University · completed · Autism Spectrum Disorder (ASD), Autism · principal investigator
- Ph2NCT01881737 · A Study of Pregnenolone in the Treatment of Individuals With AutismStanford University · completed · Autistic Disorder · principal investigator
- N/ANCT01881750 · Pivotal Response Group Treatment for Parents of Young Children With AutismStanford University · completed · Autistic Disorder · principal investigator
- Ph2NCT00676195 · An Open-Label Study of N-Acetyl Cysteine in Children With AutismStanford University · completed · Autistic Disorder · principal investigator
- Ph2NCT00627705 · A Study of N-Acetyl Cysteine in Children With AutismStanford University · completed · Autistic Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Multimodal Assessment Protocol for Characterizing Restricted and Repetitive Behaviors in AutismR01MH138412 · NIMH · STANFORD UNIVERSITY · fiscal years 2026 · $767,029 awarded in 2026Same name and institution; not confirmed by an ID
- A Randomized Controlled Double-Blind Trial of Everolimus for ImprovingSocial Abilities in PTEN Germline MutationsR01FD008531 · FDA · STANFORD UNIVERSITY · fiscal years 2026 · $647,968 awarded in 2026Same name and institution; not confirmed by an ID
- Project 2: Pharmacological Probing of Sleep Physiology in AutismP50HD109861 · NICHD · STANFORD UNIVERSITY · fiscal years 2022 to 2026 · $382,710 awarded in 2026Same name and institution; not confirmed by an ID
- Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · fiscal years 2025 to 2026 · $326,308 awarded in 2026Grant number is on one of their registry trials
- Developing a Quantitative Assessment Tool for Characterizing Social DomainsRF1MH129833 · NIMH · STANFORD UNIVERSITY · fiscal years 2025 · $1,425,865 awarded in 2025Same name and institution; not confirmed by an ID
- Developing a Quantitative Assessment Tool for Characterizing Social DomainsR01MH129833 · NIMH · STANFORD UNIVERSITY · fiscal years 2022 to 2024 · $743,927 awarded in 2024Same name and institution; not confirmed by an ID
- A Big Data Approach Toward the Development of a New Quantitative Measure of Restricted and Repetitive BehaviorsR21MH121876 · NIMH · STANFORD UNIVERSITY · fiscal years 2020 to 2021 · $197,125 awarded in 2021Same name and institution; not confirmed by an ID
- Intranasal vasopressin treatment in children with autismR01HD091972 · NICHD · STANFORD UNIVERSITY · fiscal years 2017 to 2021 · $581,063 awarded in 2021Same name and institution; not confirmed by an ID
- Neuroimaging Predictors of Pivotal Response Treatment in Young Childrenwith AutismR21DC016089 · NIDCD · STANFORD UNIVERSITY · fiscal years 2018 to 2019 · $196,250 awarded in 2019Grant number is on one of their registry trials
- Identification of RDoC Social Communication Sub-Constructs Using Existing DatasetsR03MH111846 · NIMH · STANFORD UNIVERSITY · fiscal years 2017 to 2018 · $78,500 awarded in 2018Same name and institution; not confirmed by an ID
- 2/2-Early Intervention for Youth at Risk for Bipolar DisorderR01MH093666 · NIMH · STANFORD UNIVERSITY · fiscal years 2016 · $271,215 awarded in 2016Same name and institution; not confirmed by an ID
- Quantitative Measurements of Cortical Excitability in Neurodevelopmental DisorderR21MH104774 · NIMH · STANFORD UNIVERSITY · fiscal years 2015 to 2016 · $197,500 awarded in 2016Same name and institution; not confirmed by an ID
- Pivotal Response Treatment Package for Young Children with AutismR21DC013689 · NIDCD · STANFORD UNIVERSITY · fiscal years 2014 to 2015 · $198,618 awarded in 2015Grant number is on one of their registry trials
- The role of vasopressin in the social deficits of autismR21MH100387 · NIMH · STANFORD UNIVERSITY · fiscal years 2013 to 2014 · $196,250 awarded in 2014Same name and institution; not confirmed by an ID
- A neuroimaging study of twin pairs with autismR01MH083972 · NIMH · STANFORD UNIVERSITY · fiscal years 2009 to 2013 · $599,326 awarded in 2013Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:18 UTC. The ranking covers the 200 most relevant of 26 PubMed records, and a shared surname and initials can bring in a namesake. All 26 on PubMed
- Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.Proc Natl Acad Sci U S A · 2017269 citationsRCR 12.1
- A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.Biol Psychiatry · 2012200 citationsRCR 6.7
- A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.Sci Transl Med · 2019138 citationsRCR 7.3
- A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism.J Child Psychol Psychiatry · 2015121 citationsRCR 6.4
- Inositol as an add-on treatment for bipolar depression.Bipolar Disord · 200085 citationsRCR 2.6
- Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial.Cell Host Microbe · 202481 citationsRCR 14.0
- Guanfacine in children with autism and/or intellectual disabilities.J Dev Behav Pediatr · 200877 citationsRCR 2.6
- Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.J Child Adolesc Psychopharmacol · 201771 citationsRCR 3.2
- A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder: An RCT.Pediatrics · 201970 citationsRCR 5.4
- Case study: risperidone treatment of children and adolescents with developmental disorders.J Am Acad Child Adolesc Psychiatry · 199657 citationsRCR 2.8